Section Arrow
Quote
PTHL.NASDAQ
- Pheton Holdings Ltd
(Financial Status)
Quotes are at least 15-min delayed:2025/12/08 18:43 EST
After Hours
Last
 0.548
-0.018 (-3.18%)
Bid
0.51
Ask
0.55
High 0.577 
Low 0.505 
Volume 188 
Regular Hours (Closed)
Last
 0.566
-0.003 (-0.53%)
Day High 
0.595 
Prev. Close
0.569 
1-M High
0.660001 
Volume 
185.98K 
Bid
0.51
Ask
0.55
Day Low
0.501 
Open
0.565 
1-M Low
0.5201 
Market Cap 
9.70M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.58 
20-SMA 0.59 
50-SMA 0.64 
52-W High 32 
52-W Low 0.472 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.05/--
Enterprise Value
9.70M
Balance Sheet
Book Value Per Share
0.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
448.20K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.1984+0.0214+12.09%-- 
After Hours 0.1988 +0.0004 +0.20%
BSXBoston Scientific Corp93.84-3.68-3.77%52.15PE
After Hours 93.7 -0.14 -0.15%
BFLYButterfly Network3.14+0.08+2.61%-- 
After Hours 3.13 -0.01 -0.32%
ABTAbbott Laboratories122.09-2.99-2.39%15.71PE
After Hours 122.25 +0.16 +0.13%
WOKWORK Medical Technology Group LTD.4.85-0.38-7.27%-- 
After Hours 4.94 +0.09 +1.86%
Industry overview quotes are at least 15 minutes delayed
Business Description
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy.FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.